EDIGENE
EdiGene is dedicated to the development of genome editing technology for human health. Genome editing technology enables the targeted modification of genetic information in human cells, including gene knockout, knock-in and targeted mutations. They aim at providing the high quality products and services for the patients, the pharmaceutical industry, and the scientific research community with the most advanced genome editing technology.EdiGene innovates and applies genome editing technology to developing human therapeutic products. Their therapeutic approach is to treat diseases at the molecular level, making gene therapy safer and more effective.
EDIGENE
Industry:
Biotechnology Genetics Health Care
Founded:
2015-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.edigene.com
Total Employee:
51+
Status:
Active
Contact:
010-8073 3899
Email Addresses:
[email protected]
Total Funding:
179.66 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Apache Mobile Non Scaleable Content Euro DigiCert SSL Pound Sterling
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Color
Color is a complete platform for healthcare delivery.
CureGenetics
Cure Genetics is a biotechnology company that develops innovative medicines & molecular diagnostics to treat cancers & genetic diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Qitan Technology
Qitan Technology is a Developer of a genome sequencing technology.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
BioTrack Capital
BioTrack Capital investment in Series B - EdiGene
3H Health Investment
3H Health Investment investment in Series B - EdiGene
Loyal Valley Capital
Loyal Valley Capital investment in Series B - EdiGene
Sequoia Capital China
Sequoia Capital China investment in Series B - EdiGene
Alwin Capital
Alwin Capital investment in Series B - EdiGene
Sherpa Venture Capital
Sherpa Venture Capital investment in Series B - EdiGene
Huagai Capital
Huagai Capital investment in Series B - EdiGene
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - EdiGene
IDG Capital
IDG Capital investment in Series B - EdiGene
Kunlun Capital
Kunlun Capital investment in Series B - EdiGene
Official Site Inspections
http://www.edigene.com
- Host name: 47.95.119.17
- IP address: 47.95.119.17
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
